Showing 3811-3820 of 7903 results for "".
Beyond DEWS II
https://crstoday.com/crst-issues/apr-2024/beyond-dews-ii/45268/An overview of the latest advances in dry eye disease management, treatment innovations, and insights into the condition’s pathophysiology since the landmark TFOS DEWS II report.Best Practices on Referring Patients With Symptomatic Vitreous Opacities
https://crstoday.com/crst-supplements/best-practices-on-referring-patients-with-symptomatic-vitreous-opacities/best-practices-on-referring-patients-with-symptomatic-vitreous-opacities-2/44775/Endophthalmitis Prophylaxis: What’s Changed?
https://crstoday.com/crst-issues/sept-2021/endophthalmitis-prophylaxis-whats-changed/44552/In the 20 years since CRST’s first issue, more specifics on the treatment of this infection have been elucidated, and eye surgeons are on the cusp of optimizing the use of antibiotics.State of the Industry
https://crstoday.com/topics/general/state-of-the-industry/44136/Let’s Talk About Corneal Inlays
https://crstoday.com/topics/cornea/lets-talk-about-corneal-inlays/43516/Many patients seeking LASIK do not know about this presbyopia-correcting option.Laser Cataract Surgery in Pediatric Patients
https://crstoday.com/topics/general/laser-cataract-surgery-in-pediatric-patients/43225/Children are not little adults.Update: Bargains No More
https://crstoday.com/topics/general/update-bargains-no-more/43007/The drama of prescription drug pricing continues.Q&A With Glaukos CEO Thomas Burns
https://crstoday.com/topics/general/qa-with-glaukos-ceo-thomas-burns/42888/The process of validating a new category in glaucoma and transitioning from a startup to a public company.News
https://crstoday.com/topics/general/news/42887/The Clinical Features of Migraine With and Without Aura
https://crstoday.com/topics/general/the-clinical-features-of-migraine-with-and-without-aura/42786/Patients often mistake their disorder for something else.